• new product

Esaote presents the world premiere of its new MyLabÔäóX90 ultrasound device

PRNewswire January 26, 2023

An innovative premium system combining outstanding performance with artificial intelligence to optimize workflows and support advanced and interconnected healthcare systems

MANAMA, Bahrain, Jan. 26, 2023 /PRNewswire/ — Today┬áEsaote, a leading Italian company in the biomedical sector ÔÇô in ultrasound, dedicated MRI and medical ITÔÇô presents the world premiere of MyLabÔäóX90, its new premium ultrasound system.

MyLabÔäóX90,Esaote new premium ultrasound system.

“Accuracy and precision across the entire image generation chain, data processing speed and native AI-based application management lie at the heart of MyLabÔäóX90,” said Guillaume Gauthier, Ultrasound Global Product Marketing Manager.┬á “As well as providing high-quality images and advanced clinical solutions, our aim was to revolutionize daily workflows by increasing the speed and accuracy of analysis, together with improving the operator experience and the clinical outcome for patients.”

MyLabÔäóX90 offers premium components, where the starting points are the renewal of the XCrystal probe family and the exclusive dual-layer eLed monitor by Barco. These ensure outstanding on-screen image display at a very high contrast resolution, far superior to other product lines.

MyLabÔäóX90 also offers advanced ergonomics in clinical solutions focused on the operator, which extend data analysis capacity and ensure a unique customer experience based on diagnostic confidence, as well as on automation to improve the usability and availability of advanced technologies in everyday clinical practice.

“We are highly satisfied with this outcome, the result of substantial investment and intense work on R&D. The new MyLabÔäóX90, with its all-Italian design, represents a further evolution in the range of technologies we provide to assist with people’s care and well-being,” noted Franco Fontana, CEO of Esaote. “It represents the upshot of strategic investment and of our international, multidisciplinary team, who can tackle the challenges of innovation and anticipate requirements in the most advanced and interconnected healthcare systems. We believe that these aspects, combined with the latest technologies, can contribute significantly to improving the level of patient care, and are delighted to play an active role.”

For its world premiere Esaote selected Manama, an international context and a vibrant multicultural hub. The event, that will be attended by  the Bahraini authorities and by international clinical experts will be livestreamed on Esaote LinkedIn page (https://www.linkedin.com/events/mylab-x90livestreaming-a-i-augm7021420599726026753/) and will then be available on demand at mylabx90.com .

The new MyLabÔäóX90 will be showcased at Arab Health 2023 (Dubai, January 30 – February 2), and at the European Congress of Radiology (ECR) 2023, in Vienna from March 1 to 5.

510(k) pending at FDA, not available for sale in USA.


The Esaote Group, which last year celebrated 40 years of activity, is a leader in the biomedical equipment sector, in particular in the areas of ultrasound, magnetic resonance imaging and software for managing the diagnostic process. At the end of 2021, the Group had 1,280 employees, more than half of whom were in Italy. With headquarters in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote is present in 100 countries around the world. www.esaote.com


SOURCE Esaote S.p.A.

AAPR aggregates press releases and media statements from around the world to assist our news partners with identifying and creating timely and relevant news.

All of the press releases published on this website are third-party content and AAP was not involved in the creation of it. Read the full terms.